BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fode MM, Bak-Fredslund K, Petersen JB, Worm E, Sørensen M, Høyer M. A phase I study on stereotactic body radiotherapy of liver metastases based on functional treatment planning using positron emission tomography with 2-[18F]fluoro-2-deoxy-d-galactose. Acta Oncol 2017;56:1614-20. [PMID: 28849688 DOI: 10.1080/0284186X.2017.1366051] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou P, Zhang Y, Zhang Q, Zhang G, Yu H, Zhang S. Functional Liver Imaging in Radiotherapy for Liver Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2022;12:898435. [DOI: 10.3389/fonc.2022.898435] [Reference Citation Analysis]
2 Sørensen M, Fode MM, Petersen JB, Holt MI, Høyer M. Effect of stereotactic body radiotherapy on regional metabolic liver function investigated in patients by dynamic [18F]FDGal PET/CT. Radiat Oncol 2021;16:192. [PMID: 34598730 DOI: 10.1186/s13014-021-01909-z] [Reference Citation Analysis]
3 Dreher C, Linde P, Boda-Heggemann J, Baessler B. Radiomics for liver tumours. Strahlenther Onkol 2020;196:888-99. [PMID: 32296901 DOI: 10.1007/s00066-020-01615-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
4 Overgaard J, Muren LP, Høyer M, Grau C. BIGART 2019 - adapting to the future. Acta Oncol 2019;58:1323-7. [PMID: 31642743 DOI: 10.1080/0284186X.2019.1657587] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]